Skip to main content

Table 2 Peripheral blood lymphocyte quantification

From: Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome

 

CD4:CD8 ratio

CD3CD4 (%)

CD3CD4 106cells/L

CD3CD8 (%)

CD3CD8 106cells/L

CD16CD56 (%)

CD16CD56 106cells/L

no-fatigue controls (n = 32)

2.43 (0.97)

51.1 (8.2)

990 (376)

22.9 (5.5)

440 (198)

11.7 (6.7)

210 (99)

PI-CFS/ICF (n=24)

2.05 (0.76)

50.5 (7.0)

939 (366)

27.0 (7.0)

497 (207)

7.5 (3.5)**

130 (54)**

  PI-CFS (n = 19)

2.01 (0.77)

50.3 (6.9)

912 (296)

27.5 (7.0)*

497 (200)

8.0 (3.6)*

138 (55)**

Fatigue other cause (n=12)

2.37 (1.14)

51.9 (8.1)

1132 (543)

26.1 (10.4)

635 (531)

8.7 (4.6)

186 (139)

Fatigue recovered (n=12)

1.80 (0.82)*

46.1 (10.3)

834 (318)

28.8 (9.1)*

545 (225)

10.6 (9.0)

203 (188)

no-FGID (n=26)

2.74 (1.06)

53.3 (8.6)

1008 (363)

21.1 (5.4)

394 (167)

11.3 (7.1)

192 (80)

All FGID (n=54)

1.96 (0.75)**

48.9 (7.7)*

958 (415)

27.6 (7.6)***

555 (311)**

9.1 (5.6)

176 (129)

 PI-FGID (n=45)

2.00 (0.78)**

49.2 (7.9)*

949 (418)

27.1 (7.35)**

537 (313)*

8.8 (5.4)

169 (122)

  PI-IBS (n=23)

1.97 (0.91)**

49.5 (8.8)

988 (463)

28.2 (7.1)**

592 (376)*

8.1 (5.0)*

157 (111)

no-FGID/no-fatigue controls (n=23)

2.65 (1.05)

52.4 (8.8)

974 (380)

21.5 (5.5)

389 (171)

11.8 (7.6)

194 (86)

FGID&CFS/ICF(n=23)

2.01 (0.75)*

50.2 (7.0)

923 (366)

27.3 (6.9)**

500 (211)

7.4 (3.5)**

127 (53)*

FGID, no fatigue (n=21)

1.82 (0.65)**

46.9 (8.5)*

924 (356)

27.9 (7.3)**

548 (214)**

11.0 (7.0)

223 (156)

Fatigue other cause w/wo FGID (n=12)

2.37 (1.14)

51.9 (8.1)

1133 (543)

26.1 (10.4)

635 (531)

8.7 (4.6)

186 (140)

  1. * p < 0.05 level compared to the control group (in italics) in each categorization.
  2. ** Significant at p<0.01 level compared to the control group (in italics) in its categorization.
  3. *** Significant at p<0.001 level compared to the control group (in italics) in its categorization.
  4. CD4:CD8 T-cells ratio, CD4 and CD8 T-cell subsets, CD16CD56 natural killer cells percentages and concentrations by analysis categorizations and relevant subgroups. All values are given as mean (SD). Data for the subgroups of PI-CFS, PI-FGID and PI-IBS are also given (indented).